Non-invasive and continuous hematocrit measurement by optical method without calibration

被引:0
作者
Ekuni, Shota [1 ]
Sankai, Yoshiyuki [2 ]
机构
[1] School of Integrative and Global Majors, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki
[2] Faculty of Engineering, Information and Systems, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki
关键词
Extracorporeal circulation apparatus; Hematocrit; Near-infrared spectroscopy; Thrombosis;
D O I
10.1541/ieejeiss.135.387
中图分类号
R318.08 [生物材料学]; Q [生物科学];
学科分类号
07 ; 0710 ; 0805 ; 080501 ; 080502 ; 09 ;
摘要
Hematocrit monitoring in an extracorporeal circulation apparatus is required for detection of adverse events such as hypotension and bleeding. Nevertheless we have researched non-invasive and continuous hematocrit measurements using optical methods, it remains a challenge to measure absolute levels of hematocrit without calibration. The purpose of this study is to develop an optical hematocrit measurement method without calibration, and to confirm the effectiveness in in-vitro blood experiments. We have developed an improvement method for dual wavelength and detector model by maximizing the difference of optical path lengths. Based on the proposed method, a measurement system has been developed. In the basic blood experiment, the correlation of hematocrit and calculated values by the proposed method has been confirmed. Then, we have conducted hematocrit measurement experiments with attachment errors and change of blood flow. The data indicate that the accuracy of the proposed method without calibration has been equivalent to that of an invasive method, which is employed in clinical practice. In conclusion, we have confirmed that the proposed method is effective for non-invasive and continuous hematocrit measurements. © 2015 The Institute of Electrical Engineers of Japan.
引用
收藏
页码:387 / 395
页数:8
相关论文
共 19 条
[1]  
Marlinski E., Jacobs G., Deirmengian C., Jarvik R., Durability testing of components for the Jarvik 2000 completely implantable axial flow left ventricular assist device, ASAIO J., 44, 5, pp. M741-M744, (1998)
[2]  
Akimoto T., Yamazaki K., Litwak P., Litwak K.N., Tagusari O., Mori T., Antaki J.F., Kameneva M.V., Watach M.J., Umezu M., Tomioka J., Kormos R.L., Koyanagi H., Griffith B.P., Rotary blood pump flow spontaneously increases during exercise under constant pump speed: Results of a chronic study, Artif. Organs, 23, 8, pp. 797-801, (1999)
[3]  
Dowling R.D., Etoch S.W., Stevens K.A., Johnson A.C., Gray L.A., Current status of the AbioCor implantable replacement heart, Ann. Thorac. Surg., 71, 3, pp. S147-S149, (2001)
[4]  
Copeland J.G., Smith R.G., Arabia F.A., Nolan P.E., McClellan D., Tsau P.H., Sethi G.K., Bose R.K., Banchy M.E., Covington D.L., Slepian M.J., Total artificial heart bridge to transplantation: A 9-year experience with 62 patients, J. Hear. LUNG Transplant., 23, 7, pp. 823-831, (2004)
[5]  
Yamane T., Kosaka R., Nishida M., Maruyama O., Yamamoto Y., Kuwana K., Kawamura H., Shiraishi Y., Yambe T., Sankai Y., Tsutsui T., Enhancement of hemocompatibility of the MERA monopivot centrifugal pump: Toward medium-term use, Artif. Organs, 37, 2, pp. 217-221, (2013)
[6]  
Kim K.E., Neff M., Cohen B., Somerstein M., Chinitz J., Onesti G., Swartz C., Blood volume changes and hypotension during hemodialysis, ASAIO Trans., 16, 1, pp. 508-514, (1970)
[7]  
Daugirdas J., Dialysis hypotension: A hemodynamic analysis, Kidney Int., 39, 2, pp. 233-246, (1991)
[8]  
Lins L.E., Hedenborg G., Jacobson S.H., Samuelson K., Tedner B., Zetterholm U.B., Ljungqvist O., Blood pressure reduction during hemodialysis correlates to intradialytic changes in plasma volume, Clin Nephrol., 37, 6, pp. 308-313, (1992)
[9]  
Tohgi H., Yamanouchi H., Murakami M., Kameyama M., Importance of the hematocrit as a risk factor in cerebral infarction, Stroke, 9, 4, pp. 369-374, (1978)
[10]  
Wannamethee G., Perry I.J., Shaper A.G., Hematocrit, hypertension and risk of stroke, J. Intern. Med., 235, 2, pp. 163-168, (1994)